Endocrinology Flashcards
reference ranges for fasting glucose
below 6 is normal
6.1-6.9 is prediabetes
above 7 is diabetes
reference ranges for HbA1c
below 41 is normal
42-47 is prediabetes
above 48 is diabetes
what value on random glucose would indicate diabetes
11.1
how would you manage an asymptomatic patient with an abnormal HbA1c or fasting glucose
second abnormal reading is required before diagnosis
management of diabetes with HbA1c above 48 and 53
48: lifestyle and metformin
53: lifestyle and drugs which can cause hypoglycaemia
first line management of diabetes
metformin
management of diabetic patients with high risk of CVD/current CVD/ heart failure
establish metformin then add an SGLT2 inhibitor
if metformin contraindicated then monotherapy with SGLT2
management if metformin not tolerated
switch to modified release metformin
second line therapy of diabetes
continue metformin and add one of
DPP-4 inhibitor
Pioglitazone
Sulfonylurea
SGLT2 inhibitor
third line therapy of diabetes
add another drug
start insulin therapy
when would you add a GLP-1 mimetic
under specialist care if triple therapy is not tolerated or contraindicated
which drug reduces the peripheral breakdown of incretins
DPP4 inhibitor e.g. sitagliptin
which patients are DPP4 inhibitors useful in
obese patients
which drug is an agonist of PPAR-gamma receptors and reduces peripheral insulin resistance
pioglitazone
(thiazolidinediones)
2 contraindications for pioglitazone
heart failure
bladder cancer
give an example of a sulfonylurea
gliclazide
2 side effects of sulfonylureas
weight gain and hypoglycaemia
which drug increases urinary excretion of glucose
SGLT2 inhibitors e.g. dapagliflozoin
side effects of SGLT2 inhibitors
UTI, necrotising fasciitis of the genitals, increased urine output, weight loss
how can you distinguish between type 1 and 2 diabetes on blood tests
T1DM has reduced c-peptide levels and anti-GAD autoantibodies
first line treatment of T1 diabetes
basal bolus
2 daily insulin detemir
glucose targets in type 1 diabetes
5-7 on waking
4-7 before meals
sick day rules for people on insulin
continue insulin as normal but check blood sugar levels more frequently
everyone treated with insulin needs what
a glucagon kit for emergencies
management of DKA
initially 0.9% NaCl
0.1 mg/kg/hr fixed rate insulin infusion
withhold for 1 hour in children due to the risk of cerebral oedema
continue long acting insulin
if the ketones and acidosis have not resolved within 24 hours
senior endocrinology review
pH, ketones and bicarb levels in DKA resolution
pH 7.3, ketones 0.6, bicarb 15
presentation and monitoring for hyperosmolar hyperglycaemic state
similar to DKA but hyperglycaemia with no acidosis
monitor the serum osmolarity
management of hypoglycaemia
alert: oral glucose
unconscious: 200ml 20% glucose IV
management of diabetes induced gastroparesis
metoclopramide
inheritance and treatment for MODY
autosomal dominant (strong FHx)
sulfonylureas
HbA1c in hereditary spherocytosis
underestimates blood glucose levels
MOA of orlistat
inhibits gastric and pancreatic lipase to reduce fat absorption
what is the triad in an insulinoma
whipples triad
- hypoglycaemia with fasting/exercise
- reversal of sx when given glucose
- recorded low BMs when sx occur
what are the references for BMI
under 18.5 : underweight
18.5-25: normal
25-30: overweight
30-35: obese class 1
35-40: obese class 2
above 40: obese class 3
2 main causes of hyperthyroidism
toxic multinodular goitre
graves disease
toxic multinodular goitre - treatment and scan findings
patchy uptake on scan
give radioactive iodine
graves disease - treatment and scan findings
increased homogenous uptake
propanolol in new pts for sx control
carbimazole
side effect of carbimazole
agranulocytosis
inform immediately if sore throat, fever, malaise
3 findings in graves disease
thyroid eye disease
pretibial myxoedema
clubbing (acropachy)
management of thyroid eye disease
urgent referral
periods in hyper and hypo thyroid
hyper: oligomenorrhoea or amenorrhoea
hypo: menorrhagia
management of hyperthyroid in pregnancy
propylthiouracil as reduced risk of congenital malformations
risk of over replacement of thyroxine
graves